MARKET

CERS

CERS

Cerus Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.070
-0.130
-3.10%
After Hours: 4.070 0 0.00% 16:30 01/17 EST
OPEN
4.240
PREV CLOSE
4.200
HIGH
4.280
LOW
4.020
VOLUME
1.12M
TURNOVER
--
52 WEEK HIGH
6.88
52 WEEK LOW
3.700
MARKET CAP
577.98M
P/E (TTM)
-7.9695
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CERS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CERS News

  • Cerus announces interim 2019 product revenue
  • Seeking Alpha - Article.6d ago
  • Cerus Q4 Product Revenue $20.9M From $16.5M YoY
  • Benzinga.6d ago
  • Cerus Sees 2020 Product Revenue of $89M to $93M
  • Benzinga.6d ago
  • Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2019 Product Revenue
  • Business Wire.6d ago

More

Industry

Medical Equipment, Supplies & Distribution
+0.07%
Healthcare Equipment & Supplies
+0.29%

Hot Stocks

Name
Price
%Change

About CERS

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.
More

Webull offers Cerus Corporation (CERS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.